Novel Applications of Anticoagulation with Bivalirudin in Cardiac Surgery
Main Article Content
Downloads
Article Details
Copyright (c) 2020 Kumar RP, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Brieger DV, MakK.H, Kotlke-Marchant K, Topol EJ (1998) Heparin Induced thrombocytopenia. Am Coll Cardiol 31: 1449-1459.
Aouifi A, Blanc P, Pinou V, Bastien OH, Ffrench P, et al. (2001) Cardiac surgery with cardiopulmonary bypass in patients with type II heparin induced thrombocytopenia. Ann Thorac Surg 71: 678-683. Link: https://bit.ly/3nUOndd
Furukawa K, Ohteki H, Hirakata K, Narita Y, Koga S (2001) The use of Argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations. J Thorac Cardiovas Surg 122: 1255-1256. Link: https://bit.ly/3pXu5kP
Merry AF, Raudkivi PJ, Middleton NG, Dougall MMCJ, Nanad P, et al. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surgery 77: 925-931. Link: https://bit.ly/3l0LIgb
Kumar PR, Nazer YA (2018) New Dynamic Indian Correction for Mitral Valve repairs- non resectional neochordal graded reconstruction. Asian Annals of Cardiac Surgery.
Pradeep Kumar R, Nazer YA (2018) Video technique on New Dynamic Indian Correction for mitral valve repair. submitted to CTS net video session.
Pradeep Kumar R, Rajakumar, Murugan, Nazer YA (2018) Total Arterial Revascularization: Bypassing Antediluvian Notions. EC cardiology 4: 167-169. Link: https://bit.ly/3l3Is3w
Koster A, Spiess B, Chew DP, Krabatsch T, Tambeur L, et al. (2004) Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol 93: 356-359. Link: https://bit.ly/2KCcAXh
Zucker ML, Koster A, Prats J, Laduca FM (2002) Sensitivity of a modified ACT Test to levels of bivalirudin used during cardiac surgery. J Extra Corpor Tech 37: 364-368. Link: https://bit.ly/2HtkFw7
Dyke CM, Smedira NG, Koster AA, Aroson S, Mc carthy CCP, et al. (2006) Comparison of Bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: The Evolution On study. J Thorac Cardiovas Surg 131: 5339. Link: https://bit.ly/39dPMY2
Stratmann G, de Silva AM, Tseng EE, Julie H, Michel B, et al. (2004) Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin induced thrombocytopenia. .Anaesth Anlag 98:1635-1639. Link: https://bit.ly/360q86Y
Pishko AM, Cuker A (2017) Heparin-induced thrombocytopenia in cardiac surgery patients. Semin Thromb Hemost. 43: 691-698. Link: https://bit.ly/2KBI7so
Hassen K, Maccaroni MR, Sabry H, Mukherjee S, Serumadar S, et al. (2018) Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox) anticoagulation. Perfusion 33: 235-240. Link: https://bit.ly/3m0JI8Z
Seelhammer TG, Rowse P, Yalamuri S (2020) Bivalirudin for Maintenance Anticoagulation during Venovenous Extracorporeal Membrane Oxygenation for COVID -19. J Cardiothoracic Vasc Anesth. Link: https://bit.ly/39nJsxt
Rimans J, Sylvester KW, Connors JM (2017) Direct Thrombin inhibitor for LVAD thrombosis A Closer Look Clinc Apl Throm Hemost 23: 405-409. Link: https://bit.ly/363AymJ